{"id":407266,"date":"2021-01-04T07:03:32","date_gmt":"2021-01-04T12:03:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407266"},"modified":"2021-01-04T07:03:32","modified_gmt":"2021-01-04T12:03:32","slug":"cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/","title":{"rendered":"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CAMBRIDGE, Mass., Jan.  04, 2021  (GLOBE NEWSWIRE) &#8212; Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced that it will present a corporate overview at upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li>39th Annual J.P. Morgan Healthcare Conference. A presentation and Q&amp;A discussion will take place on Thursday, January 14, 2021 at 3:40 p.m. ET and a live webcast may be accessed within the Investors &amp; Media section of the\u00a0<a href=\"http:\/\/cyclerion.com\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Cyclerion.com<\/a>\u00a0website. An archived replay will be available for approximately 90 days following the presentation.<\/li>\n<li>H.C. Wainwright BioConnect Conference. An on-demand presentation will be available on Monday January 11, 2021 at 6:00 a.m. ET at the conference <a href=\"https:\/\/hcwevents.com\/bioconnect\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">website<\/a>.<\/li>\n<\/ul>\n<p>\n        <strong>About\u00a0Cyclerion Therapeutics\u00a0<\/strong><br \/>\n        <br \/>Cyclerion Therapeutics\u00a0is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative medicines for people with serious diseases of the central nervous system (CNS). Cyclerion\u2019s lead program is CY6463 a pioneering CNS-penetrant sGC stimulator in clinical development for Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS) and Alzheimer&#8217;s Disease with Vascular pathology (ADv).<\/p>\n<p>For more information about Cyclerion, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bvBx8mYulec5QCWuhZnPkcd0JVWMgojFtsPTnG6pi-RkWRPFekDT112Mlsxe6gOoPT1lawb5Hc5VahmiVDeBs6cG37tS1ZLihZeeZHvFPGc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.cyclerion.com\/<\/a>\u00a0and follow us on Twitter (@Cyclerion) and LinkedIn (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7fGBf0-2-RMjtI0aes8ccCL0P__5WWHCqwCrBwbdYDTUPziFL4nX7xw2jZSFor8hZaQG4U0OrgbeU6eHgQ0d-oq3cI4rU7yOXaXdOsrhKXIUOx_7Tg96q4iHx2Z7RiIYvtN-jppFkUWosTOHRf_iZg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.linkedin.com\/company\/cyclerion<\/a>).<\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Carlo Tanzi, Ph.D.<br \/>Kendall Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-3hAO1r0yQ-Pt_0-p3MGcuBL91QygJ8psWA6_yMZEweg3EfjtNu1Kdnr5ZGHk7dNlS5rYy4VjojroQJN26ITVI85HqFsuwj3a0hIl9bXwNo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ctanzi@kendallir.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/415b9488-34d4-4ba8-aa52-05c4fc6a1cb4\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced that it will present a corporate overview at upcoming investor conferences: 39th Annual J.P. Morgan Healthcare Conference. A presentation and Q&amp;A discussion will take place on Thursday, January 14, 2021 at 3:40 p.m. ET and a live webcast may be accessed within the Investors &amp; Media section of the\u00a0Cyclerion.com\u00a0website. An archived replay will be available for approximately 90 days following the presentation. H.C. Wainwright BioConnect Conference. An on-demand presentation will be available on Monday January 11, 2021 at 6:00 a.m. ET at the conference website. About\u00a0Cyclerion Therapeutics\u00a0 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407266","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced that it will present a corporate overview at upcoming investor conferences: 39th Annual J.P. Morgan Healthcare Conference. A presentation and Q&amp;A discussion will take place on Thursday, January 14, 2021 at 3:40 p.m. ET and a live webcast may be accessed within the Investors &amp; Media section of the\u00a0Cyclerion.com\u00a0website. An archived replay will be available for approximately 90 days following the presentation. H.C. Wainwright BioConnect Conference. An on-demand presentation will be available on Monday January 11, 2021 at 6:00 a.m. ET at the conference website. About\u00a0Cyclerion Therapeutics\u00a0 &hellip; Continue reading &quot;Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T12:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference\",\"datePublished\":\"2021-01-04T12:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/\"},\"wordCount\":230,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/\",\"name\":\"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=\",\"datePublished\":\"2021-01-04T12:03:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/","og_locale":"en_US","og_type":"article","og_title":"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious diseases of the central nervous system (CNS), today announced that it will present a corporate overview at upcoming investor conferences: 39th Annual J.P. Morgan Healthcare Conference. A presentation and Q&amp;A discussion will take place on Thursday, January 14, 2021 at 3:40 p.m. ET and a live webcast may be accessed within the Investors &amp; Media section of the\u00a0Cyclerion.com\u00a0website. An archived replay will be available for approximately 90 days following the presentation. H.C. Wainwright BioConnect Conference. An on-demand presentation will be available on Monday January 11, 2021 at 6:00 a.m. ET at the conference website. About\u00a0Cyclerion Therapeutics\u00a0 &hellip; Continue reading \"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T12:03:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference","datePublished":"2021-01-04T12:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/"},"wordCount":230,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/","name":"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=","datePublished":"2021-01-04T12:03:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcwMiMzOTAyMzQ2IzIxMjUwMjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cyclerion-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-and-h-c-wainwright-bioconnect-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cyclerion to Participate in the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407266"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407266\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}